166 related articles for article (PubMed ID: 32116853)
1. Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients.
Losenkov IS; Mulder NJV; Levchuk LA; Vyalova NM; Loonen AJM; Bosker FJ; Simutkin GG; Boiko AS; Bokhan NA; Wilffert B; Hak E; Schmidt AF; Ivanova SA
Front Psychiatry; 2020; 11():38. PubMed ID: 32116853
[TBL] [Abstract][Full Text] [Related]
2. Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients.
Ochi T; Vyalova NM; Losenkov IS; Levchuk LA; Osmanova DZ; Mikhalitskaya EV; Loonen AJM; Bosker FJ; Simutkin GG; Bokhan NA; Wilffert B; Ivanova SA
J Affect Disord; 2019 Dec; 259():432-439. PubMed ID: 31611000
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
6. Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients.
Aldoghachi AF; Tor YS; Redzun SZ; Lokman KAB; Razaq NAA; Shahbudin AF; Badamasi IM; Cheah PS; Stanslas J; Veerakumarasivam A; Rosli R; Ibrahim N; Lye MS; Ling KH
PLoS One; 2019; 14(1):e0211241. PubMed ID: 30677092
[TBL] [Abstract][Full Text] [Related]
7. Brain‑derived neurotrophic factor gene polymorphisms are associated with coronary artery disease‑related depression and antidepressant response.
Liu YQ; Su GB; Duan CH; Wang JH; Liu HM; Feng N; Wang QX; Liu XE; Zhang J
Mol Med Rep; 2014 Dec; 10(6):3247-53. PubMed ID: 25324022
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor gene polymorphisms, neurotransmitter levels, and depressive symptoms in an elderly population.
Czira ME; Wersching H; Baune BT; Berger K
Age (Dordr); 2012 Dec; 34(6):1529-41. PubMed ID: 21898033
[TBL] [Abstract][Full Text] [Related]
9. Relationships between serum BDNF and the antidepressant effect of acute exercise in depressed women.
Meyer JD; Koltyn KF; Stegner AJ; Kim JS; Cook DB
Psychoneuroendocrinology; 2016 Dec; 74():286-294. PubMed ID: 27697714
[TBL] [Abstract][Full Text] [Related]
10. Association of circulating BDNF levels with BDNF rs6265 polymorphism in schizophrenia.
Kumar PK; Mitra P; Ghosh R; Sharma S; Nebhinani N; Sharma P
Behav Brain Res; 2020 Sep; 394():112832. PubMed ID: 32726665
[TBL] [Abstract][Full Text] [Related]
11. Thyroid stimulating hormone and serum, plasma, and platelet brain-derived neurotrophic factor during a 3-month follow-up in patients with major depressive disorder.
Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Lee D; Heo JY; Jeon HJ
J Affect Disord; 2014 Dec; 169():112-7. PubMed ID: 25189990
[TBL] [Abstract][Full Text] [Related]
12. Association of BDNF gene missense polymorphism rs6265 (Val66Met) with three quantitative traits, namely, intelligence quotient, body mass index, and blood pressure: A genetic association analysis from North India.
Fatma R; Chauhan W; Shahi MH; Afzal M
Front Neurol; 2022; 13():1035885. PubMed ID: 36742047
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
Zakharyan R; Boyajyan A
Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
[TBL] [Abstract][Full Text] [Related]
14. Lower levels of brain-derived neurotrophic factor are associated with melancholic psychomotor retardation among depressed inpatients.
Primo de Carvalho Alves L; Sica da Rocha N
Bipolar Disord; 2018 Dec; 20(8):746-752. PubMed ID: 29516593
[TBL] [Abstract][Full Text] [Related]
15. BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy.
Ryan KM; Dunne R; McLoughlin DM
Brain Stimul; 2018; 11(5):1123-1131. PubMed ID: 29802070
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study.
Aydemir O; Deveci A; Taneli F
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):261-5. PubMed ID: 15694233
[TBL] [Abstract][Full Text] [Related]
17. Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor.
Xiao L; Correll CU; Feng L; Xiang YT; Feng Y; Hu CQ; Li R; Wang G
CNS Spectr; 2019 Jun; 24(3):313-321. PubMed ID: 29460712
[TBL] [Abstract][Full Text] [Related]
18. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
[TBL] [Abstract][Full Text] [Related]
19. BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients.
Colle R; Deflesselle E; Martin S; David DJ; Hardy P; Taranu A; Falissard B; Verstuyft C; Corruble E
Pharmacogenomics; 2015; 16(9):997-1013. PubMed ID: 26122862
[TBL] [Abstract][Full Text] [Related]
20. BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression: to be submitted to: European Neuropsychopharmacology.
Schosser A; Fischer-Hansal D; Swoboda MM; Ludwig B; Carlberg L; Swoboda P; Kienesberger K; Bernegger A; Fuxjäger M; Zotter M; Schmelzle N; Inaner M; Koller R; Kapusta ND; Haslacher H; Aigner M; Kasper S; Senft B
Eur Neuropsychopharmacol; 2022 May; 58():103-108. PubMed ID: 35453068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
